C. Perry Siatis's most recent trade in Abbvie Inc was a trade of 18,008 Common Stock, $0.01 par value done at an average price of $210 . Disclosure was reported to the exchange on Feb. 28, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Abbvie Inc | Perry C. Siatis | EVP, GC AND SECRETARY | Sale of securities on an exchange or to another person at price $ 210.00 per share. | 28 Feb 2025 | 18,008 | 4,619 (0%) | 0% | 210 | 3,781,680 | Common Stock, $0.01 par value |
Abbvie Inc | Perry C. Siatis | EVP, GC AND SECRETARY | Payment of exercise price or tax liability using portion of securities received from the company at price $ 205.02 per share. | 28 Feb 2025 | 7,870 | 14,511 (0%) | 0% | 205.0 | 1,613,507 | Common Stock, $0.01 par value |
Abbvie Inc | Perry C. Siatis | EVP, GC AND SECRETARY | Sale or transfer of securities back to the company at price $ 0.00 per share. | 28 Feb 2025 | 7,775 | 15,549 | - | - | Option (Right to buy) | |
Abbvie Inc | Perry C. Siatis | EVP, GC AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 175.28 per share. | 28 Feb 2025 | 7,775 | 22,627 (0%) | 0% | 175.3 | 1,362,802 | Common Stock, $0.01 par value |
Abbvie Inc | Perry C. Siatis | EVP, GC AND SECRETARY | Sale or transfer of securities back to the company at price $ 0.00 per share. | 28 Feb 2025 | 7,315 | 7,314 | - | - | Option (Right to buy) | |
Abbvie Inc | Perry C. Siatis | EVP, GC AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 149.62 per share. | 28 Feb 2025 | 7,315 | 14,852 (0%) | 0% | 149.6 | 1,094,470 | Common Stock, $0.01 par value |
Abbvie Inc | Perry C. Siatis | EVP, GC AND SECRETARY | Sale of securities on an exchange or to another person at price $ 206.62 per share. | 28 Feb 2025 | 6,811 | 4,982 (0%) | 0% | 206.6 | 1,407,289 | Common Stock, $0.01 par value |
Abbvie Inc | Perry C. Siatis | EVP, GC AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 144.54 per share. | 28 Feb 2025 | 2,918 | 7,537 (0%) | 0% | 144.5 | 421,768 | Common Stock, $0.01 par value |
Abbvie Inc | Perry C. Siatis | EVP, GC AND SECRETARY | Sale or transfer of securities back to the company at price $ 0.00 per share. | 28 Feb 2025 | 2,918 | 0 | - | - | Option (Right to buy) | |
Abbvie Inc | Perry C. Siatis | EVP, GC AND SECRETARY | Sale of securities on an exchange or to another person at price $ 205.38 per share. | 28 Feb 2025 | 2,718 | 11,793 (0%) | 0% | 205.4 | 558,223 | Common Stock, $0.01 par value |
Abbvie Inc | Perry C. Siatis | EVP, GC AND SECRETARY | Sale of securities on an exchange or to another person at price $ 207.19 per share. | 28 Feb 2025 | 363 | 4,619 (0%) | 0% | 207.2 | 75,210 | Common Stock, $0.01 par value |
Abbvie Inc | Perry C. Siatis | EVP, GC AND SECRETARY | Sale of securities on an exchange or to another person at price $ 198.12 per share. | 20 Feb 2025 | 3,994 | 22,381 (0%) | 0% | 198.1 | 791,291 | Common Stock, $0.01 par value |
Abbvie Inc | Perry C. Siatis | EVP, GC AND SECRETARY | Sale of securities on an exchange or to another person at price $ 197.40 per share. | 20 Feb 2025 | 1,784 | 26,375 (0%) | 0% | 197.4 | 352,162 | Common Stock, $0.01 par value |
Abbvie Inc | Perry C. Siatis | EVP, GC AND SECRETARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 21,875 | 21,875 | - | - | Option (Right to buy) | |
Abbvie Inc | Perry C. Siatis | EVP, GC AND SECRETARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 5,792 | 22,529 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
Abbvie Inc | Perry C. Siatis | EVP, GC AND SECRETARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 5,630 | 28,159 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
Abbvie Inc | Perry C. Siatis | EVP, GC AND SECRETARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 4,496 | 14,893 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
Abbvie Inc | Perry C. Siatis | EVP, GC AND SECRETARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 1,844 | 16,737 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
Abbvie Inc | Perry C. Siatis | EVP, GC AND SECRETARY | Payment of exercise price or tax liability using portion of securities received from the company at price $ 178.99 per share. | 28 Feb 2024 | 7,885 | 20,288 (0%) | 0% | 179.0 | 1,411,336 | Common Stock, $0.01 par value |
Abbvie Inc | Perry C. Siatis | EVP, GC AND SECRETARY | Sale of securities on an exchange or to another person at price $ 177.05 per share. | 28 Feb 2024 | 6,504 | 13,784 (0%) | 0% | 177.0 | 1,151,533 | Common Stock, $0.01 par value |
Abbvie Inc | Perry C. Siatis | EVP, GC AND SECRETARY | Sale of securities on an exchange or to another person at price $ 178.04 per share. | 28 Feb 2024 | 3,387 | 10,397 (0%) | 0% | 178.0 | 603,021 | Common Stock, $0.01 par value |
Abbvie Inc | Siatis Perry C. | EVP, GC AND SECRETARY | Sale of securities on an exchange or to another person at price $ 177.51 per share. | 23 Feb 2024 | 13,753 | 28,173 (0%) | 0% | 177.5 | 2,441,295 | Common Stock, $0.01 par value |
Abbvie Inc | C. Siatis Perry | EVP, GC AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 7,315 | 14,629 | - | - | Option (Right to buy) | |
Abbvie Inc | Perry C. Siatis | EVP, GC AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 149.62 per share. | 23 Feb 2024 | 7,315 | 41,926 (0%) | 0% | 149.6 | 1,094,470 | Common Stock, $0.01 par value |
Abbvie Inc | Perry C. Siatis | EVP, GC AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 105.92 per share. | 23 Feb 2024 | 3,519 | 34,611 (0%) | 0% | 105.9 | 372,732 | Common Stock, $0.01 par value |
Abbvie Inc | Perry C. Siatis | EVP, GC AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 3,519 | 0 | - | - | Option (Right to buy) | |
Abbvie Inc | Siatis Perry C. | EVP, GC AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 144.54 per share. | 23 Feb 2024 | 2,919 | 31,092 (0%) | 0% | 144.5 | 421,912 | Common Stock, $0.01 par value |
Abbvie Inc | Perry Siatis C. | EVP, GC AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 2,919 | 2,919 | - | - | Option (Right to buy) | |
Abbvie Inc | Siatis C. Perry | EVP, GC AND SECRETARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 23,324 | 23,324 | - | - | Option (Right to buy) | |
Abbvie Inc | Siatis C. Perry | EVP, GC AND SECRETARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 8,022 | 18,399 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
Abbvie Inc | Perry Siatis C. | EVP, GC AND SECRETARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 5,792 | 28,173 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
Abbvie Inc | Perry Siatis C. | EVP, GC AND SECRETARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 2,138 | 20,537 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
Abbvie Inc | Perry C. Siatis | EVP, GC AND SECRETARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 1,844 | 22,381 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
Abbvie Inc | C. Perry Siatis | EVP, GC AND SECRETARY | Grant, award, or other acquisition of securities at price $ 144.54 per share. | 02 Feb 2024 | 2,919 | 13,296 (0%) | 0% | 144.5 | 421,912 | Common Stock, $0.01 par value |
Abbvie Inc | C. Siatis Perry | EVP, GC AND SECRETARY | Sale or transfer of securities back to the company at price $ 170.00 per share. | 02 Feb 2024 | 2,919 | 10,377 (0%) | 0% | 170 | 496,230 | Common Stock, $0.01 par value |
Abbvie Inc | Siatis Perry C. | EVP, GC AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2024 | 2,919 | 5,837 | - | - | Option (Right to buy) | |
Abbvie Inc | Perry C. Siatis | EVP, GC AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Apr 2023 | 3,520 | 3,520 | - | - | Option (Right to buy) | |
Abbvie Inc | Perry C. Siatis | EVP, GC AND SECRETARY | Sale of securities on an exchange or to another person at price $ 160.00 per share. | 03 Apr 2023 | 3,520 | 10,377 (0%) | 0% | 160 | 563,200 | Common Stock, $0.01 par value |
Abbvie Inc | Perry C. Siatis | EVP, GC AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 105.92 per share. | 03 Apr 2023 | 3,520 | 13,897 (0%) | 0% | 105.9 | 372,838 | Common Stock, $0.01 par value |
Abbvie Inc | Perry C. Siatis | EVP, GC AND SECRETARY | Sale of securities on an exchange or to another person at price $ 153.06 per share. | 28 Feb 2023 | 11,330 | 11,182 (0%) | 0% | 153.1 | 1,734,170 | Common Stock, $0.01 par value |
Abbvie Inc | Perry C. Siatis | EVP, GC AND SECRETARY | Payment of exercise price or tax liability using portion of securities received from the company at price $ 154.28 per share. | 28 Feb 2023 | 9,656 | 22,512 (0%) | 0% | 154.3 | 1,489,728 | Common Stock, $0.01 par value |
Abbvie Inc | Perry C. Siatis | EVP, GC AND SECRETARY | Sale of securities on an exchange or to another person at price $ 153.38 per share. | 28 Feb 2023 | 805 | 10,377 (0%) | 0% | 153.4 | 123,471 | Common Stock, $0.01 par value |
Abbvie Inc | Perry C. Siatis | EVP, GC AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2023 | 7,364 | 0 | - | - | Option (Right to buy) | |
Abbvie Inc | Perry C. Siatis | EVP, GC AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 93.50 per share. | 21 Feb 2023 | 7,364 | 39,532 (0%) | 0% | 93.5 | 688,534 | Common Stock, $0.01 par value |
Abbvie Inc | Perry C. Siatis | EVP, GC AND SECRETARY | Sale of securities on an exchange or to another person at price $ 151.29 per share. | 21 Feb 2023 | 3,933 | 32,168 (0%) | 0% | 151.3 | 595,024 | Common Stock, $0.01 par value |
Abbvie Inc | Perry C. Siatis | EVP, GC AND SECRETARY | Sale of securities on an exchange or to another person at price $ 150.73 per share. | 21 Feb 2023 | 3,431 | 36,101 (0%) | 0% | 150.7 | 517,155 | Common Stock, $0.01 par value |
Abbvie Inc | Perry C. Siatis | EVP, GC AND SECRETARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 21,944 | 21,944 | - | - | Option (Right to buy) | |
Abbvie Inc | Perry C. Siatis | EVP, GC AND SECRETARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 14,437 | 24,814 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
Abbvie Inc | Perry C. Siatis | EVP, GC AND SECRETARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 3,368 | 28,182 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
Abbvie Inc | Perry C. Siatis | EVP, GC AND SECRETARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 2,140 | 30,322 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
Abbvie Inc | Perry C. Siatis | EVP, GC AND SECRETARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 1,846 | 32,168 (0%) | 0% | 0 | Common Stock, $0.01 par value |